Food News and Research

RSS

Researchers develop oral vaccine against Helicobacter pylori

Researchers from Southern Medical University in Guangdong, Guangzhou, China, have developed an oral vaccine against Helicobacter pylori, the bacteria responsible for peptic ulcers and some forms of gastric cancer, and have successfully tested it in mice. The research is published ahead of print in the journal Clinical and Vaccine Immunology.

20 Dec 2013

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.

From Baxter International Inc. 20 Dec 2013

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

19 Dec 2013

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes.

19 Dec 2013

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.

19 Dec 2013

European research project to develop new rapid diagnostic devices

Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducting research for three years under the European LabOnFoil project to develop new rapid diagnostic devices.

19 Dec 2013

Viewpoints: New healthcare.gov czar knows something about computer bugs; fears about inadequate drug coverage

Seriously, one has to hope the new guy -- Kurt DelBene, former head of the Microsoft Office Division -- brings only a portion of Microsoft's heritage along with him. Aside from the XBox, the software giant isn't known for great consumer experiences. Its products have been maddeningly complex and notoriously buggy, at least in their early versions. Kind of like HealthCare.gov! (Jon Healey, 12/17).

19 Dec 2013

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.

19 Dec 2013

Scientists report new development toward long-sought insulin pill for diabetes treatment

Since insulin's crucial discovery nearly a century ago, countless diabetes patients have had to inject themselves with the life-saving medicine. Now scientists are reporting a new development toward a long-sought insulin pill that could save millions the pain of daily shots. Published in the ACS journal Biomacromolecules, the advance could someday not only eliminate the "ouch" factor, but also get needle-wary - and weary - patients to take their medicine when they should.

19 Dec 2013

Study finds relationship between quality of children's diets and elders in representative communities

Understanding how dietary habits are connected through the generations could have valuable benefits for community health, a new study shows.

18 Dec 2013

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Mylan Inc. today announced that it has received all regulatory approvals and has completed an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize a novel long-acting muscarinic antagonist compound for various indications.

18 Dec 2013

Oticon Medical obtains FDA clearance to market Ponto Plus bone anchored sound processors

Oticon Medical has obtained 510(k) clearance from the U.S. Food and Drug Administration to market Ponto Plus, the company's newest family of bone anchored sound processors. New Ponto Plus is available in regular and power versions and is designed for use with Oticon Medical's proprietary OptiFit/OptiGrip implant design concepts that have also been cleared by the FDA for use in tissue-preserving surgery.

18 Dec 2013

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted for standard review the Company's supplemental Biologics License Application for EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema.

18 Dec 2013

Omeros' OMS721 receives FDA orphan drug designation for prevention of TMAs

Omeros Corporation today announced that OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system, has received orphan drug designation from the U.S. Food and Drug Administration for prevention of complement-mediated thrombotic microangiopathies.

18 Dec 2013

New global survey reveals that Australia trails behind other countries on important health issues

Despite Australia’s reputation around the world as a land of keen sportsmen and healthy outdoor living, a new global survey has revealed the country is far behind many other nations on a number of important health issues; including exercise, weight, healthy eating and alcohol consumption.

18 Dec 2013

Extracts from pecan shells may be effective at protecting meats

The majority of consumers that eat or buy organic products do not want synthetic antimicrobials or antioxidants added to their foods and prefer a "clean label". A study in the Journal of Food Science published by the Institute of Food Technologists (IFT) showed that extracts from pecan shells may be effective at protecting meats, such as chicken from listeria growth.

18 Dec 2013

Innovation leads to faster drug therapies, increased understanding of proteins on microscopic level

Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of "force microscopes" that are available to researchers and the one-dimensional results these microscopes reveal.

17 Dec 2013

Food News and Research

Researchers develop oral vaccine against Helicobacter pylori

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

European research project to develop new rapid diagnostic devices

Viewpoints: New healthcare.gov czar knows something about computer bugs; fears about inadequate drug coverage

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Scientists report new development toward long-sought insulin pill for diabetes treatment

Study finds relationship between quality of children's diets and elders in representative communities

Mylan obtains exclusive rights from Pfizer to develop, commercialize novel LAMA compound

Oticon Medical obtains FDA clearance to market Ponto Plus bone anchored sound processors

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

Omeros' OMS721 receives FDA orphan drug designation for prevention of TMAs

New global survey reveals that Australia trails behind other countries on important health issues

Extracts from pecan shells may be effective at protecting meats

Innovation leads to faster drug therapies, increased understanding of proteins on microscopic level

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

Addition of oregano oils to sunflower seeds preserves positive sensory attributes, freshness quality

UCLA scientists receive $21M grant to conduct groundbreaking clinical trials on stem cell science

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News